GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » EPS (Diluted)

Microba Life Sciences (ASX:MAP) EPS (Diluted) : A$-0.05 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences EPS (Diluted)?

Microba Life Sciences's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was A$-0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.05.

Microba Life Sciences's EPS (Basic) for the six months ended in Dec. 2023 was A$-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.05.

Microba Life Sciences's EPS without NRI for the six months ended in Dec. 2023 was A$-0.03. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Microba Life Sciences EPS (Diluted) Historical Data

The historical data trend for Microba Life Sciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences EPS (Diluted) Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
EPS (Diluted)
-0.05 -0.04

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) - -0.05 -0.02 -0.02 -0.03

Competitive Comparison of Microba Life Sciences's EPS (Diluted)

For the Diagnostics & Research subindustry, Microba Life Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microba Life Sciences's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's PE Ratio falls into.



Microba Life Sciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Microba Life Sciences's Diluted EPS for the fiscal year that ended in Jun. 2023 is calculated as

Diluted EPS (A: Jun. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-12.68-0)/332.990
=-0.04

Microba Life Sciences's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-11.488-0)/372.279
=-0.03

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microba Life Sciences  (ASX:MAP) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Microba Life Sciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines